TerminatedNot Applicable

Long-Term Follow-Up of Transplanted Human Central Nervous System Stem Cells (HuCNS-SC) in Spinal Cord Trauma Subjects

Stopped: Based on a business decision unrelated to any safety concerns.

Switzerland12 participantsStarted 2012-11

Plain-language summary

The purpose of this study is to determine the long term safety and preliminary efficacy of intramedullary transplantation of HuCNS-SC cells in subjects with thoracic spinal cord trauma.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Must have undergone HuCNS-SC transplantation as a subject in the Phase I/II trial * Must agree to comply in good faith with all conditions of the study and to attend all required study visits Exclusion Criteria: * Subjects have received or are receiving off-protocol immunosuppressive medications * Subjects who, after completion of Phase I/II trial (Protocol # CL-N02-SC), have entered or are about to enter any other investigational study.

What they're measuring

American Spinal Injury Association (ASIA) Impairment Scale Improvement

Timeframe: Four years

Trial details

NCT IDNCT01725880

SponsorStemCells, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2016-05

View on ClinicalTrials.gov More Spinal Cord Injury trials